Trial intelligence / Profile preview

Polynucleotide injection for hypertrophic scars and keloids (abdominal, split-scar)

TCTR20240630003Phase 1Unknown

Start
Feb 2024
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in Hypertrophic Scar (HS) and keloid (2 arms), sponsored by none. Status: unknown.

02

Conditions

Hypertrophic Scar (HS)keloid

Beyond the preview

Go deeper on TCTR20240630003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240630003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call